1-11 of 11
interleukin-15
Close
Sort by
Journal Articles

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Clinical Trials & Observations
Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2387–2391.
https://doi.org/10.1182/bloodadvances.2019000664
Published: 2020
Journal Articles

Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells

Xiaomei Wang, Daniel L. Jasinski, Jan L. Medina, David M. Spencer, Aaron E. Foster, J. Henri Bayle
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1950–1964.
https://doi.org/10.1182/bloodadvances.2020001510
Published: 2020
Includes: Supplemental data
Journal Articles

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation

Li Li, Han Chen, David Marin, Yuanxin Xi, Qi Miao, Jiangxing Lv, Pinaki Prosad Banerjee, Hila Shaim, May Daher, Rafet Basar, Nobuhiko Imahashi, Juan Jimenez, Bingqian Hu, Rohtesh S. Mehta, Lucila Nassif Kerbauy, Mecit Kaplan, Mayela Mendt, Gonca Ozcan, Elif Gokdemir, Mayra Hernandez Sanabria, Ye Li, Ken Chen, Jing Wang, Luis Muniz-Feliciano, Wei-Li Zhao, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4117–4130.
https://doi.org/10.1182/bloodadvances.2019000835
Published: 2019
Includes: Supplemental data
Journal Articles

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Clinical Trials & Observations
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1970–1980.
https://doi.org/10.1182/bloodadvances.2018028332
Published: 2019
Includes: Supplemental data
Journal Articles

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F. Kaminski, Sarah Cooley, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller, Veronika Bachanova
Journal: Blood Advances
Blood Adv (2019) 3 (6): 897–907.
https://doi.org/10.1182/bloodadvances.2018029371
Published: 2019
Includes: Supplemental data
Journal Articles

IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice

Yimin Shi, Lillia Dincheva-Vogel, Charles E. Ayemoba, Jeffrey P. Fung, Cristina Bergamaschi, George N. Pavlakis, Farzin Farzaneh, Karin M. L. Gaensler
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3177–3192.
https://doi.org/10.1182/bloodadvances.2018019026
Published: 2018
Includes: Supplemental data
Journal Articles

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS

Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd Lenvik, Peter Hinderlie, Julie Curtsinger, Erica Warlick, Stephen R. Spellman, Bruce R. Blazar, Daniel J. Weisdorf, Sarah Cooley, Daniel A. Vallera, Björn Önfelt, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1459–1469.
https://doi.org/10.1182/bloodadvances.2017012369
Published: 2018
Includes: Multimedia, Supplemental data
Journal Articles

The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis

Jiajing Qiu, Mohamed E. Salama, Cing Siang Hu, Yan Li, Xiaoli Wang, Ronald Hoffman
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1130–1145.
https://doi.org/10.1182/bloodadvances.2017015073
Published: 2018
Includes: Supplemental data
Journal Articles

The human IL-15 superagonist ALT-803 directs SIV-specific CD8 + T cells into B-cell follicles

Gabriela M. Webb, Shengbin Li, Gwantwa Mwakalundwa, Joy M. Folkvord, Justin M. Greene, Jason S. Reed, Jeffery J. Stanton, Alfred W. Legasse, Theodore Hobbs, Lauren D. Martin, Byung S. Park, James B. Whitney, Emily K. Jeng, Hing C. Wong, Douglas F. Nixon, R. Brad Jones, Elizabeth Connick, Pamela J. Skinner, Jonah B. Sacha
Journal: Blood Advances
Blood Adv (2018) 2 (2): 76–84.
https://doi.org/10.1182/bloodadvances.2017012971
Published: 2018
Includes: Supplemental data
Journal Articles

Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells

Ana Raykova, Paolo Carrega, Frank M. Lehmann, Robert Ivanek, Vanessa Landtwing, Isaak Quast, Jan D. Lünemann, Daniela Finke, Guido Ferlazzo, Obinna Chijioke, Christian Münz
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2679–2691.
https://doi.org/10.1182/bloodadvances.2017008839
Published: 2017
Includes: Supplemental data
Journal Articles

Fewer circulating natural killer cells 28 days after double cord blood transplantation predicts inferior survival and IL-15 response

Rachel J. Bergerson, Robin Williams, Hongbo Wang, Ryan Shanley, Gretchen Colbenson, Alyssa Kerber, Sarah Cooley, Julie M. Curtsinger, Martin Felices, Jeffrey S. Miller, Michael R. Verneris
Journal: Blood Advances
Blood Adv (2016) 1 (3): 208–218.
https://doi.org/10.1182/bloodadvances.2016000158
Published: 2016
Includes: Supplemental data